Replies to post #116885 on Biotech Values

[DewDiligence]

That’s true, jbog—the bulk of GILD’s cash resides in ex-US subsidiaries. Still, GILD has more than enough US-based cash to fund day to day operations, so the new raise does suggest that something might be going on with M&A.